These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8512376)

  • 1. Case management of the anemic patient: epoetin alfa--focus on adequacy of dialysis.
    Erlich L
    ANNA J; 1993 Apr; 20(2):181-4. PubMed ID: 8512376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case management of the anemic patient. Epoetin alfa: focus on dialysis efficiency.
    Latham D; Geisman J
    ANNA J; 1991 Dec; 18(6):588-9. PubMed ID: 1750793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case management of the anemic patient. Epoetin alfa: focus on reimbursement.
    Roe WI
    ANNA J; 1992 Apr; 19(2):198-9. PubMed ID: 1586234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case management of the anemic patient. Epoetin alfa: focus on hematocrit.
    Kirlin L
    ANNA J; 1992 Feb; 19(1):66-7. PubMed ID: 1546890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case management of the anemic patient. Epoetin alfa: focus on quality of life.
    Butera E
    ANNA J; 1992 Aug; 19(4):410-1. PubMed ID: 1520032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case study of the anemic patient: epoetin alfa--focus on iron management.
    Kirlin LF
    ANNA J; 1995 Apr; 22(2):192-5. PubMed ID: 7786067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 11. Case management of the anemic patient: epoetin alfa--focus on compliance.
    Currier H
    ANNA J; 1993 Aug; 20(4):470-3. PubMed ID: 8368881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients.
    Kaupke CJ; Vaziri ND; Sampson JR; Atkins K
    Int J Artif Organs; 1990 Apr; 13(4):218-22. PubMed ID: 2373550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case management of the anemic patient. Epoetin alfa: focus on pediatric dialysis patients.
    Gilman C
    ANNA J; 1992 Oct; 19(5):496-7. PubMed ID: 1456798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of epoetin alfa therapy for anemia of end-stage renal disease.
    Moran LJ; Carey P; Johnson CA
    Am J Hosp Pharm; 1992 Jun; 49(6):1451-4. PubMed ID: 1529988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient.
    Cohen JA; Brattich M
    ANNA J; 1997 Oct; 24(5):574-80; quiz 581. PubMed ID: 9392740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case study of the anemic patient: epoetin alfa--focus on improving ventricular function.
    Weil C
    ANNA J; 1995 Jun; 22(3):338-41. PubMed ID: 7786083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.
    Keown PA; Churchill DN; Poulin-Costello M; Lei L; Gantotti S; Agodoa I; Gitlin M; Gandra SR; Mayne TJ
    Hemodial Int; 2010 Apr; 14(2):168-73. PubMed ID: 20345390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary effects of erythropoietin treatment on metabolism and dialysis efficiency in stable hemodialysis patients.
    Buur T; Lundberg M
    Clin Nephrol; 1990 Nov; 34(5):230-5. PubMed ID: 2268981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoetin alfa--focus on optimal hematocrit. Case study of the anemic patient.
    Hendrix WR
    ANNA J; 1996 Feb; 23(1):46-9. PubMed ID: 8702361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.